Cupid Secures Rs. 16.23 Crore Orders For Male Condoms From Central Medical Services Society

Cupid Limited, a leading manufacturer, has garnered orders totalling Rs. 16.23 crores from the Central Medical Services Society (CMSS) for the supply of male condoms, the company informed in a press statement on Monday. Established as a Central Procurement Agency (CPA) with Cabinet approval, CMSS plays a crucial role in streamlining drug procurement and distribution for the Department of Health & Family Welfare (DoHFW), under the Ministry of Health and Family Welfare, Government of India.

Cupid successfully secured two separate orders for male condoms from CMSS, amounting to Rs. 9.65 crores and Rs. 6.58 crores, respectively. The company aims to fulfil these orders by April 2024, as disclosed in the exchange filing on January 8, 2024.

Aditya Halwasiya, Managing Director of Cupid , expressed excitement about this significant allocation from the Government of India, highlighting the company’s unwavering commitment to supporting the government’s vision of promoting a safe and healthy lifestyle for all citizens. He stated, “This collaboration underscores the importance of ensuring access to vital resources for the well-being of the community at large.”

Furthermore, Halwasiya emphasised Cupid Limited’s alignment with the Government of India’s initiative to “Help India Play Safe.” He mentioned that Cupid Limited’s proposed production capacity expansion in the next 18-24 months positions the company well for future orders from the government.

This development not only strengthens Cupid Limited’s partnership with the Government of India but also reflects the company’s dedication to contributing to public health initiatives. The successful execution of these orders is anticipated to play a vital role in advancing the accessibility of essential resources within the healthcare sector.

Related Posts

  • Pharma
  • July 9, 2025
  • 93 views
Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

Nectar Lifesciences Ltd on Tuesday said it will sell its active pharmaceutical ingredients and formulation along with menthol business assets to Ceph Lifesciences Pvt Ltd, for Rs 1,290 crore. The…

  • Pharma
  • July 9, 2025
  • 99 views
Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

That half-empty bottle of painkillers or expired anxiety pills in your drawer could do more harm than good and Apex drug regulatory body, CDSCO, has said it’s best to flush…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

Flush these 17 expired medicines now. India’s top drug regulatory body issues stern warning

Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

Sun Pharma confirms the stocks of ‘Levipil 500’ seized by Telangana DCA in raids is spurious

HC-ordered expert panel for weight loss drug may be set up by mid-July

HC-ordered expert panel for weight loss drug may be set up by mid-July